BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 29205415)

  • 1. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.
    Le Bastard Q; Al-Ghalith GA; Grégoire M; Chapelet G; Javaudin F; Dailly E; Batard E; Knights D; Montassier E
    Aliment Pharmacol Ther; 2018 Feb; 47(3):332-345. PubMed ID: 29205415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of non-antibiotic drugs on the human intestinal microbiome.
    Le Bastard Q; Berthelot L; Soulillou JP; Montassier E
    Expert Rev Mol Diagn; 2021 Sep; 21(9):911-924. PubMed ID: 34225544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
    Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
    Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.
    Bruno G; Zaccari P; Rocco G; Scalese G; Panetta C; Porowska B; Pontone S; Severi C
    World J Gastroenterol; 2019 Jun; 25(22):2706-2719. PubMed ID: 31235994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.
    Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE
    Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections.
    Thänert R; Thänert A; Ou J; Bajinting A; Burnham CD; Engelstad HJ; Tecos ME; Ndao IM; Hall-Moore C; Rouggly-Nickless C; Carl MA; Rubin DC; Davidson NO; Tarr PI; Warner BB; Dantas G; Warner BW
    Gut Microbes; 2021; 13(1):1940792. PubMed ID: 34264786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
    Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
    PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.
    Takashima S; Tanaka F; Kawaguchi Y; Usui Y; Fujimoto K; Nadatani Y; Otani K; Hosomi S; Nagami Y; Kamata N; Taira K; Tanigawa T; Watanabe T; Imoto S; Uematsu S; Fujiwara Y
    Neurogastroenterol Motil; 2020 Jul; 32(7):e13841. PubMed ID: 32319196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy Genes of Host Responds to Disruption of Gut Microbial Community by Antibiotics.
    Singh SB; Wilson M; Ritz N; Lin HC
    Dig Dis Sci; 2017 Jun; 62(6):1486-1497. PubMed ID: 28466260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antibiotics on the human microbiome: a systematic review.
    Nel Van Zyl K; Matukane SR; Hamman BL; Whitelaw AC; Newton-Foot M
    Int J Antimicrob Agents; 2022 Feb; 59(2):106502. PubMed ID: 34929293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors affect the gut microbiome.
    Imhann F; Bonder MJ; Vich Vila A; Fu J; Mujagic Z; Vork L; Tigchelaar EF; Jankipersadsing SA; Cenit MC; Harmsen HJ; Dijkstra G; Franke L; Xavier RJ; Jonkers D; Wijmenga C; Weersma RK; Zhernakova A
    Gut; 2016 May; 65(5):740-8. PubMed ID: 26657899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
    Burdet C; Sayah-Jeanne S; Nguyen TT; Hugon P; Sablier-Gallis F; Saint-Lu N; Corbel T; Ferreira S; Pulse M; Weiss W; Andremont A; Mentré F; de Gunzburg J
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis.
    McDonnell L; Gilkes A; Ashworth M; Rowland V; Harries TH; Armstrong D; White P
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33651651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics in early life: dysbiosis and the damage done.
    Neuman H; Forsythe P; Uzan A; Avni O; Koren O
    FEMS Microbiol Rev; 2018 Jul; 42(4):489-499. PubMed ID: 29945240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review.
    Garg K; Mohajeri MH
    Brain Res Bull; 2024 Feb; 207():110883. PubMed ID: 38244807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal dysbiosis in cirrhosis.
    Bajaj JS; Liu EJ; Kheradman R; Fagan A; Heuman DM; White M; Gavis EA; Hylemon P; Sikaroodi M; Gillevet PM
    Gut; 2018 Jun; 67(6):1146-1154. PubMed ID: 28578302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.